Compound ID | 411

Update compound information

BMY 28232

Class: Beta-lactam

Agent Type: Semisynthetic; Small molecule; Direct acting;
Spectrum of activity: Gram-positive & Gram-negative
Mechanism of action: Cell wall synthesis inhibitor
Description: Cephalosporin-type; active form of BMY 28271, its acetoxyethyl ester prodrug
Institute where first reported: Bristol Myers Research Institute, Ltd., Tokyo, Japan
Year first mentioned: 1988
Development status: Experimental
Chemical structure(s):
Click here for structure editor
Molecular weight: 411.46
Iso. SMILES: C/C=C/C1(CN2C(C(C2=O)NC(=O)/C(=N/O)/C3=CSC(=N3)N)SC1)C(=O)O
InChI Key: BGWUMNCHZHCHTA-FIFVVGQHSA-N
Can. SMILES: C/C=C/C1(CN2C(=O)C(C2SC1)NC(=O)/C(=N/O)/C3=CSC(=N3)N)C(=O)O
InChI: InChI=1S/C15H17N5O5S2/c1-2-3-15(13(23)24)5-20-11(22)9(12(20)27-6-15)18-10(21)8(19-25)7-4-26-14(16)17-7/h2-4,9,12,25H,5-6H2,1H3,(H2,16,17)(H,18,21)(H,23,24)/b3-2+,19-8+
External links:
PubChem link: https://pubchem.ncbi.nlm.nih.gov/compound/131715411
Citations:
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC171643/
  • https://doi.org/10.1128/aac.33.4.489

    • AntibioticDB is supported by GARDP.

    If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

    The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.